Author:
Matsumoto Manabu,Ohtsuki Yuji,Furihata Mutsuo
Reference85 articles.
1. Aaltomaa, S.H., Lipponen, P.K., Viitanen, J., Kankkunen, J.P., Ala-Opas, M.Y., and Kosma, V.M. (2000). The prognostic value of inducible nitric oxide synthase in local prostate cancer. BJU Int. 86, 234–239.
2. Ambs, S., Hussain, S.P., and Harris, C.C. (1997). Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J. 11, 443–448.
3. Ambs, S., Merriam, W.G., Bennett, W.P., Felley-Bosco, E., Ogunfusika, M.O., Oser, S.M., Klein, S., Shields, P.G., Billiar, T.R., and Harris, C.C. (1998). Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 58, 334–341.
4. Ambs, S., Bennett, W.P., Merriam, W.G., Ogunfusika, M.O., Oser, S.M., Harrington, A.M., Shields, P.G., Felley-Bosco, E., Hussain, S.P., and Harris, C.C. (1999). Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J. Natl. Cancer Inst. 91, 86–88.
5. Anayama, T., Furihata, M., Ishikawa, T., Ohtsuki, Y., and Ogoshi, S. (1998). Positive correlation between p27Kip1 expression and progression of human esophageal squamous cell carcinoma. Int. J. Cancer 79, 439–443.